Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
Shindo T, Hashimoto K, Takahashi A, Miyamoto S, Kunishima Y, Sato S, Fukuta F, Hiyama Y, Takayanagi A, Kato R, Wanifuchi A, Ueki Y, Okada M, Adachi H, Kobayashi KO, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium.
Shindo T, et al. Among authors: kobayashi ko.
Anticancer Res. 2024 Mar;44(3):1271-1279. doi: 10.21873/anticanres.16922.
Anticancer Res. 2024.
PMID: 38423657